Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis Dr. Brian Koffman provides us with a well-referenced video guide to the appropriate use of various types of face masks... November 10, 2020COVID-19, News, News about Clinical TrialsBy Brad Hedrick
TG Therapeutics Announces Positive Topline Results TG Therapeutics Announces Positive Topline Results from the UNITY-CLL Phase 3 Study Evaluating the Combination of Umbralisib and Ublituximab (U2)... May 22, 2020News about Clinical TrialsBy Brad Hedrick
It’s Clinical Trials Awareness Week! The CLL Society partners with the nonprofit Coalition for Clinical Trials Awareness to increase trial awareness and participation for CLL... May 18, 2020News about Clinical TrialsBy Brad Hedrick
CAR-T Trial for JCAR017 Now Open at USCD and 27 Other Sites Across the USA An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma... October 5, 2019News about Clinical TrialsBy Brad Hedrick
The Transcend 004 Clinical Trial The Transcend CLL 004 Clinical Trial is looking for patients with relapsed or refractory CLL/SLL. The investigational treatment uses a... July 15, 2019News about Clinical TrialsBy Brad Hedrick
A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated CLL A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated CLL offers an option of a novel agent... July 9, 2019News about Clinical TrialsBy Brad Hedrick
Two New Free Vaccine Trials at the NIH The National Institutes of Health were founded by Congress in 1887 and charged with being the preeminent research center in... April 9, 2019News about Clinical TrialsBy Brad Hedrick
Clinical Trials and our Clinical Trial Banner You may notice a new feature on the CLL Society website, a Clinical Trial Banner on our home page. As many... October 21, 2018News about Clinical TrialsBy Brad Hedrick
New trial for early stage high-risk CLL patients. The vast majority of patients (approximately 75%) with newly diagnosed CLL do not need treatment at the time of initial... October 12, 2018News about Clinical TrialsBy Brad Hedrick
Monoclonal B-cell Lymphocytosis Study Researchers at Queen’s University Belfast in the UK, are conducting the first large-scale survey of Monoclonal B-cell lymphocytosis patients and... March 16, 2018News about Clinical TrialsBy Todd Dennison
